Biotricity is trading 10% down at $0.09 amid broader risk-off trading, after no clear company-specific announcement emerged for September 10, 2026.
- The S&P 500 is down 0.73% and Nasdaq Composite is down 0.88%.
- Elevated producer inflation and firm Treasury yields are pressuring equities.
- Healthcare weakness and ongoing geopolitical oil concerns are adding to sentiment pressure.